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Proteases (also termed as peptidase or proteinase) are the enzymes that play 
the central role in the degradation of protein by hydrolyzing peptide bond that joins 
amino acids together in proteins.  Proteases are found in all the living things from 
viruses to mammalia. These enzymes are involved in a multitude of physiological 
progresses from simple digestion of food proteins (e.g., digestive proteases in saliva, 
stomach and intestines) to highly regulated cascades (e.g., the complement system 
and apoptosis pathways) Furthermore, they are associated with various disease 
such as arthritic joint erosion, atheroscleroticplaque formation, tumor invasion and 
metastasis thus represent excellent target for therapeutic intervention (Bromme and 
Wilson, 2011). Proteases can be categorized based on their substrate specificities or 
mechanisms of catalysis. Upon the basis of the mechanism of peptide hydrolysis, 
seven major protease classes are known: serine, cysteine, threonine, aspartic, 
glutamic, asparagine and metallo catalytic type. In more than 670 proteases 
expressed from human genome, 31% are serine proteases, 33% metallo proteases, 
4% aspartic protease, and 25% cysteine protease (http//merops.sanger.ac.uk). 
Proteases in which the thiol group of a cysteine residue serves as the 
nucleophile in catalysis are defined as cysteine protease (Barret and Woessner, 
1998). Cysteine proteases are widely distributed in a variety of biological tissues and 
fluid, where they involved in the process of intra- and extra-cellular protein 
degradation and turn over (Reddy et al., 1995). Papain-like cysteine proteases, 
which are also known as cysteine cathepsins, is the largest subfamily among the 
cysteine protease class (clan CA, family C1). Papain-like cysteine proteases have 
been increasingly recognized as critical enzyme activities in degenerative, invasive, 
and immune system related disorders. 
TABLE 1 
CYSTEINE PEPTIDASES BELONG TO C1 FAMILY 


















tubulointerstitial nephritis antigen C01.973
tubulointerstitial nephritis antigen-related protein C01.975
cathepsin B C01.060
dipeptidyl-peptidase I (cathepsin C) C01.070
Source: http//merops.sanger.ac.uk 
These proteases have obtained little attention since it was thought that their 
functions are restricted in lysosomes. Recent efforts in the understanding of the 
physiological roles of these enzymes using protease-deficient mouse models has 
changed this view. It becomes more and more clear that papain-like cysteine 
proteases fulfill specific functions in extracellular matrix turnover, antigen 
presentation, and processing events and that they may represent attractive target for 
the development of therapeutic inhibitors for major diseases such as osteoporosis, 
arthritis, immune-related diseases, atherosclerosis, cancer (Lecaille et al., 2002).  
Inhibitors of cysteine cathepsin 
The papain family is the largest family, the members of which include a wide 
range of enzymes from both prokaryotes and eukaryotes, encompassing bacteria, 
plants, vertebrates and invertebrates (Bertie and Storer, 1995). The proteinases of 
this family are implicated in a number of degradative, invasive and pathological 
processes. Therefore, cysteine proteinases of the papain family represent attractive 
targets for the development of therapeutic inhibitors because of their involvement in 
abnormal physiological processes. However, since they are involved in important 
roles in normal protein turnover process and also due to their broad substrate 
specificity, the development of highly selective inhibitors has been a great challenge 
(Wiederanders, 2003). Since the early 1970s, a variety of low molecular weight 
inhibitors of cysteine proteases have been discovered.  
All cysteine cathepsins are composed of a signal peptide, a propeptide, and a 
catalytic domain (Fig.1). The signal peptide, which consists of 10-20 amino acids in 
length, is cleaved off at the site of the translocation into the endoplasmic reticulum. 
The propeptide is cleaved in the increasingly acidic environment of the 
endosomal/lysosomal system resulting in a fully active catalytic domain of the 
cathepsins. To date, the pro-region has three known functions (Bromme and Wilson, 
2011): 1) acts as a scaffold for protein folding of the mature region; 2) works as 
chaperon for the transport of proenzyme to the endosomal/lysosomal compartment; 
3) potent and highly selective inhibitor of the cognate enzyme. 
Figure 1: Schematic representation of the protease domains of human 
cathepsins (Source: Bromme and Wilson, 2011)
Cytotoxic T-lymphocyte antigen-
The expression of cytotoxic T-lymphocyte antigen-2 was originally detected in 
mouse activated T-cells and mast cells (Denizot et all., 1989). It was described as a 
transcript that was induced upon activation of T-lymphocytes. Two similar, but distinct 
CTLA-2 transcripts were identified and named as CTLA- - . CTLA-
are described to have evolved from a cysteine proteinase ancestor gene through 
process of repeated duplication and translocation. CTLA- -  are highly 
homologous proteins and both of them contain 110 amino acid residues with an 
additional N-terminal hydrophobic amino acid sequence. The protein sequences of 
CTLA-  with the 42% 
homology for CTLA- and 36% homology for CTLA-2  (Yamamoto et al., 2002).  
Cysteine proteinases such as cathepsin L and cathepsin B are synthesized as 
inactive proenzymes (Turk B et al.; 2000). The N- terminal proregions of these 
proteases, which are removed during the activation process, act as potent inhibitors 
of mature enzymes (Turk B et al.; 2000). Since the proregion can fold independently, 
interest in novel inhibitor proteins from this region is increasing. The proregion is a 
part of the enzyme but CTLA-
designated as a member of the I29 peptidase inhibitor family 
(http://merops.sanger.ac.uk).  
CTLA- has been characterized and expressed as a recombinant protein 
and has been shown to selectively inhibit mouse cathepsin L-like cysteine 
proteinases (Kurata et al., 2001). Previous studies suggested that CTLA-
inhibit cathepsin L-like cysteine protease, but is less selective than CTLA-  (Delaria 
et al., 1994). One of the essential amino acid residues of CTLA-
for its inhibitory potency is cysteine 75 (C75), which is located in the vicinity of the C- 
terminal region and interacts with the active-site cleft of the enzyme (Deshapriya et 
al., 2010). 
Previous studies showed that CTLA-
mice (Campo et al.; 1996) while CTLA-
suggesting that CTLA-  et al.; 2004). 
In the mouse brain, CTLA-
neuronal populations (Luziga et al., 2007). The CTLA-
detected in neuronal dendrites and axons (Luziga et al., 2008) suggesting that 
CTLA-
that CTLA-  the eye (Mochizuki 
et al., 2010). Retinal pigment epithelium-derived CTLA-
T regulatory cells (Sugita et al., 2008, 2009, 2011). 
Objectives of this doctoral thesis 
Even though CTLA-2 is the most studied of the propeptide-like cysteine 
protease inhibitors, its inhibition mechanisms have not been fully determined. Many 
attempts have been made to explore more functionally specific sequences or 
residues for inhibition in the proregion of cysteine protease. The essential amino acid 
residues of CTLA-
suggested that a disulfide bonding between CTLA-
established when the inhibitory reaction happened (Deshapriya et al., 2010).   
On the other hand, in most of previous studies, CTLA-
to act as cathepsin L inhibitors on the above described physiological mechanisms. Its 
physiological role is not clear. A recent study revealed that CTLA-
cAMP/PKA-promoted apoptosis in murine T-lymphoma cells and cardiac fibroblasts 
(Zhang et al., 2011). This inducing mechanism was not related to the ability of CTLA-
- ious physiological 
functions that have yet to be identified. 
Armed with confidence based on essential information from previous studies, 
goal-oriented objectives were carried out step by step throughout my PhD studies to 
further elucidate the inhibitory mechanism and physiological functions of CTLA-
The results of all these objectives where discussed in further details in five chapters. 
In Chapter 1, the general information about cysteine protease and CTLA-  is 
presented. Chapter 2 reports the yeast screening of the proteins interact with CTLA-
. The highlights in Chapter 3 comprise of the association features of CTLA-  and 
other proteins in vitro and in vivo, the novel explore of the CTLA-  inhibitory activity 
toward cathepsin C in cells. The analysis and results of the co-localization of CTLA-
 and its interactive proteins in cells and tissue were discussed in the Chapter 4. 




II.1. LITERATURE REVIEW 
This chapter reports the novel finding about the interaction between CTLA-
and others protein by yeast two-hybrid system. To date, cathepsin L has been known 
as the only target protein of CTLA-
of this protein had been restricted in the manner of one of potent inhibitor of 
cathepsin L. The report from Zhang et al.,(2011) has opened the door to new view 
about CTLA- . They have found that CTLA-  expression is regulated by 
cAMP/protein kinase A- dependent mechanism and may contribute to cAMP/PKA-
promoted cells death in cells. Cathepsin L has been known to be involved in immune 
system but the role in apoptosis is not clear if it is promote or anti  apoptotic. 
Interestingly, Zhang group has found that cAMP/PKA up-regulated cathepsin L 
activity but over-expression of CTLA-  protein in cells does not change its activity. 
In simpler terms, the contribution of CTLA-  to cAMP/PKA-promoted apoptosis 
does not related to the ability of CTLA-  to inhibit cathepsin L. It was raised a 
question whether another protease participate in regulation of apoptosis by CTLA-
or in other words CTLA-  has others target protein apart from cathepsin L. It will 
thus be of interesting to identify the proteins association with CTLA- . To achieve 
the result, the yeast two-hybrid system has been applied. 
-  to 
look for new interacting proteins that are likely to association according to genetic or 
biochemical data. This system is a molecular genetic based on the advantage of the 
flexible structure of the yeast transcription factor Gal4. The Gal4 protein contains two 
domains, DNA-binding domain (DNA  BD) and activation domain (AD). These 
domains need not to be part of the same protein to activate the transcription. When 
fused separately the two domains into two unrelated but interacting proteins, the 
transcription will be activated as the result of the protein-protein interaction (Fig. 2). 
Usually, the search for new interacting proteins using yeast two-hybrid system has 
been carried out by co-transforming two vectors encoded bait protein cDNA and prey 
proteins cDNA into yeast strain. 
Source: Clontech
Figure 2: The two  hybrid principle. Bait protein is expresses as a fusion to the Gal4 
DNA  BD, while the libraries of prey protein are express as fusion to the Gal4 AD. 
When bait and prey fusion protein interact, the DNA  BD and AD are brought in to 
proximity to active transcription of four independent reporter genes. 
 In this study, CTLA-  was used as a bait protein and the prey proteins were 
searched from the universal, embryonic, and brain cDNA libraries of mouse.
II.2. MATERIALS AND METHODS 
Yeast two-hybrid screening  
Yeast two-hybrid screenings were performed using the Matchmaker Gold 
Yeast Two-Hybrid System (Clontech. CA, USA). cDNA fragments encoding mouse 
CTLA-
domain to 
toxic effects or autonomously activate the reporter genes in Y2HGold yeast strain.  
Universal, embryonic, and brain cDNA libraries from mouse were purchased (Mate & 
plateTM library, Clontech), and constructed in the pGADT7 vector containing a GAL4 
activation domain and transformed into yeast strain Y187. Positive clones were 
selected based on their ability to grow on synthetic dropout media minus leucine, 
tryptophan (SD/DDO) and minus leucine, tryptophan, histidine, adenine (SD/QDO) 
and exhibit X- -Gal activity.  
Clone isolation and interaction analysis
Yeast colony PCR analysis was performed to eliminate duplicates containing 
the same AD/library inserts. Matchmaker Insert Check PCR Mix 2 (Clontech) has 
been applied to amplify the prey library inserts. The present of more than a single 
band in electrophoresis gel indicated the present of more than one prey plasmid in a 
yeast cell. Such inserts will be re-selected and purified by precipitation PCR product. 
Next, streaking on DDO/X media has been done 2 times to segregate the non-
interacting preys. The only blue colonies have been selected. Plasmid DNAs were 
isolated from the positive clones (Easy Yeast Plasmid Isolation Kit, Clontech) and 
transformed into Escherichia coli JM109. Positive prey clone-derived plasmid DNAs 
were rescued by ampicillin resistance and positive cDNA were identified by 
nucleotide sequence analysis with the BLAST database (www.ncbi.nlm.nih.gov/blast). 
Interactions were verified by co-transforming the pGADT7 vector containing the 
by selection on SD/DDO/X and SD/-QDO/X media. 
Expression construct, cell culture and transfection  
cDNAs encode CTLA- , Cathepsin L, Cathepsin C and TINAGL1 were 
cloned into pAcGFP plasmid (for bait) and pProlabel plasmid (for preys) to generate 
pGFP-CTLA and pPro-CtsL, pPro-CtsC, pPro-TINAGL. 
 HEK293T (Human Embryonic Kidney) cells were cultured in DMEM (Wako) 
supplemented with 10% fetal bovine serum at 37 C in a humidified atmosphere 
containing 5% CO2. DNA transfection of HEK293 cells was carried out at 60% 
80% confluent using ScreenFect A (Wako)  
Co-immunoprecitaion assay for cells 
The Matchmaker Chemiluminescent Co-IP System was performed to confirm 
interactions between CTLA-  and Cathepsin L, Cathepsin C and TINAGL1 which 
have been identified through the yeast two-hybrid screening. This is a co-
immunoprecipitation method that utilizes a fluorescent AcGFP1 tag and the 
enzymatic ProLabel reporter for chemiluminescent detection of physical interactions 
between proteins that are expressed and posttranslationally modified in mammalian 
cells. After the AcGFP1- tagged bait and the ProLabel-tagged prey fusion proteins 
are co-expressed in the cells, the Matchmaker Chemiluminescent Co-IP Kit is 
performed to immunoprecipitate the bait. Then, the co-immunoprecipitation 
complexes are quantified by assaying for Prolabel activity using Prolabel Detection 
Kit.   
HEK293T cells were cultured on the 75cm2 flask and co-transfected with 
pGFP-CTLA and pPro-CtsL, pGFP-CTLA and pPro-CtsC, pGFP-CTLA and pPro-
TINAGL. The cells co-transfected with pGFP-lam and pPro-T were used as negative 
control, pGFP-p53 and pPro-T were positive control. After 48h, cells were washed 
twice with PBS and trypsinized. The cells pellets then were collected and further 
lysated . The lysated samples were 
subjected to the co-immunopecipitation assay using Protein G Plus/A Agarose Beads 
and anti-AcGFP Ab. The samples were incubated with 1 µl of anti-AcGFP Ab in 2h 
on a rotator at 40C followed by an overnight incubation with washed agarose beads.  
Next morning, the beads were pelleted at 9000 rpm/10 secs. After washing with the 
Wash Buffer 1, the pellets were suspended in the Wash Buffer 2 and ready for the 
Prolabel activity detection. The Prolabel Detection Kit was applied to assay the prey 
expressions. The Wash Buffer 2 was removed and the samples with beads were 
resuspend in 80 µl of the lysis/complementation then transferred to a well in the 94-
well plate. To each well, add 30 µl of subtrate mix and read the Prolabel activity from 
the samples at 0, 20, 45 and 70 min after addition of the subtrate. The results were 
sumarized after analyzing the plot the Prolabel reading. 
Generation of antibodies  
Recombinant CTLA- cathepsin L were purified using methods 
described previously with minor modifications (Kurata et al., 2003). Affinity purified 
rabbit anti-CTLA-2, anti-cathepsin L IgGs and  chicken anti - anti-CTLA-2, anti-
cathepsin L IgYs were obtained as described previously (Takahashi et al., 1992; 
Camenisch et al., 1999; Luziga et al., 2008). In brief, egg yolk immunoglobulin 
fractions were prepared from eggs laid by hens immunized against recombinant 
CTLA- -CTLA- -cathepsin L IgYs were 
affinity purified through columns with recombinant protein conjugated resins. Mouse 
(sc-74590) and rabbit (sc-13986) anti-cathepsin C antibodies were purchased from 
Santa Cruz Biotechnology, Inc (TX, USA). An anti-TINAGL1 antibody (ab107679) 
was purchased from Abcam (Cambridge, MA, USA).  
Co-immunoprecipitation (Co-IP) for tissue 
Complexes of CTLA- -
from pregnant mouse uterus tissue. All experiments using mouse uteri conformed to 
the 1973 law concerning the protection and control of animals (guidelines for animal 
experimentation) in Japan. Mice were anesthetized by diethyl ether, and uteri were 
taken out and quickly rinsed in 0.9% sodium chloride, then frozen, and stored at -
80ºC until future use. Frozen uteri were thawed, cut into pieces, and homogenized in 
4 vol. of buffer (0.1M Tris-Cl at pH 7.4 containing 0.3 M NaCl, 1 mM EDTA, and 0.1% 
Triton X-100). Insoluble materials were removed by centrifugation (13.000 rpm, 5 
min) and the supernatant was incubated at 37ºC for 10 min. In order to isolate the 
complexes of CTLA- athepsin L and CTLA-
was applied to anti  CTLA- -
immunoprecipitation Kit, Invitrogen, Oslo, Norway). The unbound proteins were 
removed by washing with PBS and the target proteins were specifically eluted 
immunoprecipitated with the beads omitting anti - CTLA-
analyses were performed as previously described (Luziga et al., 2008).
Pull-down assay  
The molecular weight of TINAGL1 is close to that of IgG. Therefore, It is 
impossible to distingue between TINAGL1 and IgG leaking from the beads of the Co-
IP assay. A pull-down assay was performed to determine the complex of CTLA-
1. Human Embryonic Kidney (HEK293T) cells were cultured in DMEM 
(Wako, Osaka, Japan) supplemented with 10% fetal bovine serum at 370C in a 
humidified atmosphere containing 5% CO2. Full-length cDNA encoding TINAGL1 
was cloned into a  from pFUSE-hlgG2-Fc1, InvivoGen, CA, 
USA) to generate pFU.TINAGL1 was transfected into HEK293T cells at 60%  80% 
confluence using ScreenFect A (Wako). The recombinant CTLA-2 protein, which 
contained a His-tag sequence, was prepared as described above. Recombinant 
CTLA-2 protein (7µg/ml) was added into the culture medium 24 h after transfection. 
The culture medium was then collected 7 h later and subjected to the pull-down 
assay using His tag resin (Dynabeads TALON, Invitrogen). The proteins recovered 
were subjected to 12% SDS-PAGE and analyzed by immunoblotting. For negative 
control, PBS was used in place of CTLA-2
3. RESULTS 
3.1. CTLA-2  interacts with cathepsin L, cathepsin C and TINAGL1 in yeast 
The yeast two hybrid system with the bait plasmid  was 
used to screen cDNA libraries derived from mouse tissues in order to identify mouse 
proteins that interact with CTLA-   A total 8 x 107 diploid cells were screened 
yielding 91 positive clones, after eliminating the duplicates clones and segregation 
17 of which demonstrated strongly growth on DDO/X media. The DNAs of these 
clones were isolated, sequenced, and aligned using the NCBI BLAST alignment 
system. As can be seen in the Table 2, two clones have not matched with any 
sequence in database (marked as non-sense: number 5 and 13), clone 18 has 
matched with unknown protein. The rest colonies have been selected for further step 
to confirmation the interaction. 
Among the candidate proteins, cathepsin L, cathepsin C, and TINAGL1 were 
identified to interact with CTLA- -QDO/X 
medium was observed in yeast cells co transformed with pGBKT7.CTL
pGADT7.cathepsinL, 
pGBKT7. 3A). 
The alignment of the cathepsin L, cathepsin C and TINAGL1 proteins was 
examined (Fig. 3B). The three proteins belong to the papain family, C1A 
(http://merops.sanger.ac.uk). Unlike cathepsin L and cathepsin C, TINAGL1 is not a 
peptidase. Its active cysteine residue was replaced by a serine residue (as 
highlighted in box in Fig. 3B), resulting in a proteolytically inactive protein. 
The alignment of CTLA-  and pro-region of cathepsin L (Fig. 3C), catepsin C 
(Fig 3D) proved the highly homology between CTLA-  and the pro region of these 
two cysteine proteases, 30% homology for the pro region of cathepsin L and 25% 
homology  for pro region of cathepsin C. 
3.2. CTLA-2  interacts with cathepsin L, cathepsin C and TINAGL1 in 
mammalian cells. 
Co-immunoprecitaion assay was performed to confirm the interactions 
between CTLA-  and Cathepsin L, Cathepsin C and TINAGL1 on the mammalian 
cells. The Figure 4 shows the result of Prolabel assay to detect the Prolabel activity 
from the complexes between CTLA-2
activities were observed from the positive control and 3 samples with varying levels. 
The highest level was obtained from the positive control with 1195 RLU after 70 min 
incubation while no observed activity from negative control. The cells co-transfected 
with CTLA-2
signal, reached 52 RLU after 45 min and 128 RLU after 70 min incubation with 
chemiluminescent substrate. Similarly trend but ten times lower signal was observed 
from the cells co-transfected with CTLA-2 CTLA-2
C: 14 RLU and 10 RLU after 70 min incubation, respectively. These results indicate 
that these three prey proteins have been co-immunoprecipitated with CTLA-2
the Co-IP assay. In other word, CTLA-2 athepsin L, cathepsin C and 
TINAGL1 on the mammalian cells. 
Table 2  : Sequence analysis for positive candidates from the screenings 
No 
GeneBank 
Accession No. Matched protein  
1 BC017684 
cytidine monophosphate (UMP-CMP) 
           kinase 1 
2 BC057195 ankyrin repeat domain 17 
3 BC090389 ribosomal protein S20 
4 BC027313 1600012H06Rik protein 
5   non sense 
6 BC003420 DnaJ (Hsp40) homolog, subfamily A, member 2 
7 BC067054 regulation of nuclear pre-mRNA domain containing 
8 AL672278     DNA sequence from clone RP23-465H23        
9 NP446034 Tubulointerstitial nephritis antigen-like protein 1  
10 BC067063 cathepsin C 
11 BC067063 cathepsin C 
12 J05287 lysosomal membrane glycoprotein (LAMP-2)  
13   non sense 
14 BC141031 splicing factor, arginine/serine-rich 18 
15 BC034754 archain 1 
16 U85089 thioredoxin 
17 U85089 thioredoxin 
18   un known 
 19  NP034114 Cathepsin L 
20 BC085267 splicing factor, arginine/serine-rich 5 
Figure 3A: Cathepsin L, cathepsin C, and TINAGL1 are proteins that interact 
with CTLA- . A. Three interactive proteins with CTLA-2 : cathepsin L, cathepsin C, 
and TINAGL1, were identified by yeast two-hybrid analysis. Clone 1 was a positive 
control (pGBKT7-53 and pGADT7-T). Clones 2, 3, and 4 were TINAGL1, cathepsin 
C, and cathepsin L co-transformed with CTLA-2 , respectively. Clone 5 was a 
negative control (pGBKT7-LAM and pGADT7-T). 
Figure 3B. The alignment of the interactive proteins, cathepsin L, cathepsin C, 
and TINAGL1. Highly conserved amino acid residues are shown in red. The position 
of the cysteine-replacing serine residue is marked by a box. GenBank accession 
numbers: cathepsin L: NP034114; cathepsin C: BC067063; TINAGL1 
(Tubulointerstitial nephritis antigen-like 1 precursor) NP446034. 
Figure 3C: Alignment between CTLA-  and Pro region of cathepsin L. Highly 
conserved amino acid residues are shown in red 
Figure 3D: Alignment between CTLA-  C. Highly 
conserved amino acid residues are shown in red 
II. 3.3. CTLA-2  interacts with cathepsin L, cathepsin C and TINAGL1 in tissue 
Detection of CTLA- cathepsin L and CTLA- cathepsin C complexes in the 
mouse uterus 
A previous study demonstrated that CTLA- highly expressed in the 
placenta (Campo et al., 1996). Therefore, pregnant mouse uteri were chosen to 
determine the interaction capability of CTLA-  L and cathepsin C. 
CTLA- -immunoprecipitated with cathepsin L and cathepsin C from mouse 
uterus homogenates. Figure 5 shows SDS-PAGE of two combination experiments. 
Western blot analysis using anti-cathepsin L Ab clearly showed a single protein band 
of approximately 24 kDa (Fig. 5; lane 1). By comparing with the negative control 
(lane 2), the appearance of the single band indicated that CTLA-
cathepsin L. When the same sample was probed with anti-cathepsin C Ab, only a 
single band of 25 kDa was detected (lane 3), which was not detected in the negative 
control (lane 4). This clearly indicated that the cathepsin C protein was also 
recovered from the Co-IP assay. Thus, these results indicated that cathepsin L and 
cathepsin C interacted with CTLA- .
Detection of the CTLA-
Isolation of CTLA-2 /TINAGL1 complex from pregnant mouse uteri by Co-IP 
was unsuccessful. Therefore, pull-down assay techniques was used to examine the 
interaction between CTLA- TINAGL1on HEK293T cells that overexpressed 
TINAGL1 proteins. TINAGL1 is known to be actively secreted (Wex et al., 2001) and 
part of CTLA-2 extracellularly. Therefore, recombinant CTLA-2
was added to the culture medium 24h after transfection before the pull-down assay. 
Figure 6 shows the result of two independent experiments, Western blot analysis 
before and after the assay. As shown in Figure 6, a single protein band 
corresponding to TINAGL1 could be detected in lanes 1 and 3 after probing with anti-
TINAGL1 Ab. That band was similar with the band appear in lane 3 which  The 
absence of that band in lane 2, in which CTLA-
medium, indicated that the CTLA-
down from the culture medium. 
Figure 4: Detection of Prolabel activity from bait-prey complexes. HEK293 cells 
co-transfected with AcGFP- tagged CTLA- -tagged preys (cathepsin L, 
cathepsin C or TINAGL1) were immuneprecipitated with the anti-AcGFP1 Ab and 
assayed for Prolabel activity. 
Figure 5: Isolation of CTLA-2 /cathepsin L and CTLA-2 / cathepsin C 
complexes from the mouse uterus. A 10 dpc mouse uterus extract was subjected 
to Co-IP using Anti-CTLA-
(lanes 2 and 4). The recovered proteins were subjected to 12% SDS-PAGE. Proteins 
immunoreactive to the anti-cathepsin L (lanes 1 and 2) and anti-cathepsin C (lanes 3 
and 4) antibodies were visualized. 
Figure 6: Pull-down of the recombinant CTLA-
culture medium of HEK293T cells transfected with pFU.TINAGL1. The 
recombinant His-CTLA-
medium 24h after transfection, followed by a 7-h culture. The medium was collected 
and subjected to a pull-down assay using the His-tag resin. The recovered proteins 
were subjected to 12% SDS-PAGE. Lane 3; culture medium before the pull-down 
assay. Proteins immunoreactive to the anti-TINAGL1 Ab were visualized. 
Study II 
Characterization of the interactions  
between CTLA-2
1. LITERATURE REVIEW 
Over the past decades, several cysteine proteinase inhibitor proteins 
homologous to the proregion of papain like cysteine proteinases have been reported 
(Yamamoto et al., 2002): bombyx cysteine proteinase inhibitors (BCPIs) (Yamamoto 
et al., 1999; Kurata et al., 2001), cytotoxic T-lymphocyte antigen-2s (CTLA-2s) 
(Delaria et al.; 1994; Kurata et al., 2003). BCPI (BCPI-a and b) are cysteine 
proteinase inhibitor proteins, which are found in the hemolymph of the silkmoth 
Bombyx mori and are homologous to the proregion of certain cysteine proteinases 
including Bombyx cysteine proteinase and are highly selective inhibitors of cathepsin 
L-like cysteine proteinases (Yamamoto et al., 1999; Kurata et al., 2001). CTLA-2s 
genes are mapped to the C1 band of mouse chromosome number 13, which 
encodes 109 amino acid residues with additional amino-terminal hydrophobic amino 
acid sequences, the transcripts of which were originally found in mouse activated T-
lymphocytes and mast cells. The amino acid sequences of CTLA-2 are highly 
homologous to those of mouse cathepsin L. Recombinant CTLA-2s have been 
shown to be potent, competitive inhibitors of cathepsin L-like cysteine proteases. We 
previously identified the essential amino acid residues of CTLA-
inhibitory potency (Deshapriya et al., 2007). Three Trp residues (W12, W15, and 
-helixes, which form the hydrophobic core structure between the 
-helix, significantly contributed to inhibition. Another essential 
amino acid residue was shown to be cysteine 75 (C75), which is located in the 
immediate vicinity of the CTLA- -site cleft 
of the enzyme. We also suggested the possibility of disulfide bonding between 
CTLA- In the chapter, we attempted to elucidate the functional 
roles of the cysteine residue in more detail and clarify the interacting characterization 
between CTLA-  and cathepsin L, cathepsin C.  
2. MATERIAL AND METHODS 
Expression of CTLA- T cells.
Full-length cDNA encoding CTLA-
(modified from pFUSE-hlgG2-Fc1). HEK293T cells (human embryonic kidney cells) 
were cultured and maintained in DMEM medium supplemented with 10% fetal calf 
serum. Transfection was performed using Lipofectamine LTX and PLUS according to 
the instructions provided by the manufacturer. After 48h culturing, the whole cell 
lysate and culture medium were collected and subjected to SDS-PAGE. Western 
blotting was carried out according to the method described previously (Luziga et al., 
2008).  
Monomer- Dimer conversion of CTLA-
The dimeric form of CTLA- °C in 
500 µl of the reducing buffer (150 mM NaCl, 1 mM EDTA, 50 mM DTT, and 100 mM 
Tris-Cl, pH 7.4). After incubation, the buffer was replaced by equilibration buffer (150 
mM NaCl, 1 mM EDTA, 100 mM Tris-Cl, pH 8.2) containing or not containing 2 mM 
GSSG using a PD MiniTrap G-25 column. The samples were further incubated at 
4°C overnight. The inhibition assay and SDS-PAGE analysis were then performed. 
For the inhibition assays towards CtsL, 30 µl of the CTLA-
the assay buffer (500 µl) as described above. 
Isolation of CTLA- cathepsin L complex. 
Cathepsin L and CTLA-
(1 mM EDTA, 8 mM cysteine, and 100 mM sodium acetate, pH 5.0) at 37°C. After 5 
min. the buffer was quickly exchanged with buffer containing 150 mM NaCl, 1 mM 
EDTA, and 100 mM Tris-Cl, pH 7.4 by gel filtration using a PD MiniTrap G-25 column. 
The sample was then further incubated for 20 min at 37°C. In order to isolate the 
CTLA- cathepsin L complex, an aliquot of the incubated sample was applied to a 
His-bind resin (Dynabeads TALON). The unbound proteins were removed by 
washing and the target proteins containing CTLA- cathepsin L complex were 
surements of 
cathespin L enzyme activity, an aliquot of the complex fraction was incubated in 0.1 
M sodium acetate (pH 5.5) or 0.1 M sodium phosphate (pH 7.4) containing 1 mM 
EDTA, 8 mM cysteine. The enzyme reaction was started by the addition of Z-Phe-
Arg-MCA (10 µM). The progress curves were monitored continuously for 5 min at 
37°C at excitation and emission wavelengths of 370 and 460 nm with a 
spectrofluorometer (model F2000, Hitachi). SDS-PAGE and immunoblotting 
analyses were performed as described previously (Luziga et al., 2008). Affinity 
purified rabbit anti- CTLA-  and anti-cathepsin L antibodies were prepared as
described previously (Luziga et al., 2009).  
Simple cell-based fluorescence assay for cathepsin C activity in live cells 
Cathepsin C activity was detected as previously described (Thong et al., 
2011) with some modifications. Cos-7 cells (derived from the kidney of the African 
Green monkey) were cultured in DMEM (Wako) supplemented with 10% fetal bovine 
serum at 37°C in a humidified atmosphere containing 5% CO2. The cDNA encoding 
cathepsin C was cloned into the pBApo-CMV Neo DNA plasmid (Takara, Osaka, 
Japan) to generate pBApo.Cathepsin C, which was then transfected into Cos-7 cells.
Cathepsin C-expressing Cos-7 cells were selected on neomycin (G-418 sulfate 
solution, WAKO). After a 1-week selection, the transient cathepsin C-expressing cells 
were sequentially transfected with the pFU.CTLA- plasmid, which contained cDNA 
encoding CTLA- . The activity of cathepsin C in live cells was examined using a 
fluorogenic, cell-permeant, peptide substrate glycyl-phenylalanyl- amino-fluoro-
coumarin (GF-AFC, Promega Corporation, WI, USA). The cells were washed in PBS, 
followed by a 1h incubation with PBS containing GF-AFC (100µM), DMSO (1%), and
2 min with DAPI (4',6-diamidino-2-phenylindole) for nuclear staining. Images were 
captured using a BZ-9000E HS all-in-one Fluorescence Microscope (KEYENCE, 
Japan) -7 cells and cathepsin C-
expressing Cos-7 cells were used as negative and positive controls, respectively.   
3. RESULTS 
3.1. Expression of CTLA- rom HEK293T cells
  The CTLA- T cells, which 
demonstrated the existence of both intra- and extracellular functions (Fig. 7). The 
expressed protein could be present as the monomeric and dimeric form. Most of the 
CTLA-
3.2. Monomer  Dimmer conversion of CTLA-
As described above, CTLA-
dimeric form. CTLA-
constructed mutant CTLA-
serine residue (C75A, C75S). The dimeric form of CTLA-
by SDS-PAGE of such mutant proteins, suggesting that the dimeric form of CTLA-
resulted from the formation of an intermolecular disulfide bond between monomers. 
Interestingly, the inhibitory activity of the cysteine mutants (C75A, C75S) was 
markedly reduced. As a further investigation of the functional roles of the cysteine 
residue, we first isolated the dimeric form of CTLA-
monomeric form (Figure 8, lane 2). It was fully inhibitory against CtsL. By treating it 
with the strong reducing reagent, DTT, the dimeric form lost all its inhibitory activity, 
and was completely converted to the monomeric form (Figure 8, lane 3). The 
preparation was then subjected to gel filtration to remove DTT, and further incubated 
in the absence or presence of L-glutathione (oxidized, GSSG). After overnight 
incubation, a part of the monomeric form was reassembled to the dimeric form, and 
recovered trace amounts of inhibitory activity (Figure 8, lane 4). Interestingly, in the 
presence of GSSG, CTLA-
molecular form remained mostly as the monomeric form (Figure 8, lane 5). The 
possibility of inhibition of cathepsin L by GSSG could be omitted because GSSG (up 
to 1 mM) did not exhibit inhibitory activity towards cathepsin L in the present assay 
system (data not shown), and a final concentration of GSSG of the assay mixture 
containing CTLA- . 
                       .             
Figure 7. CTLA- T cells. Samples were subjected to SDS-
PAGE using 12 % polyacrylamide gels in the absence of 2-mercaptoethanol, and 
analyzed by Western blotting using an anti- CTLA- ne 1, cell extract; 
lane 2, medium
Figure 8. Dimer-monomer conversion of CTLA- . SDS-PAGE using 15% 
polyacrylamide gels was performed in the absence of 2-mercaptoethanol. Proteins 
were stained with Coomassie brilliant blue. Lane 1, protein molecular weight 
standards; lane 2, dimeric form of CTLA-
mM DTT; lane 4, sample of lane 3 further incubated in the absence of DTT; lane 5, 
sample of lane 3 further incubated in the absence of DTT and in the presence of 2 
mM GSSG. RA, relative inhibition activity towards cathepsin L, activity of the dimeric 
form of CTLA-
3.3. Identification of the CTLA-2 / cathepsin L complexes conjugated with a 
disulfide bond in vitro
 Since cathepsin L is a cysteine protease having an essential cysteine residue 
at its active site, we next attempted to isolate the CTLA-
conjugated with a disulfide bond. CTLA-
preincubated for a short time in an acidic buffer (pH 5.0) containing cysteine to 
activate cathepsin L and allow the interaction between CTLA-
The buffer was quickly exchanged with a neutral buffer (pH 7.4) not containing 
cysteine. After incubation, CTLA- -
recovered by precipitation with the His-bind resin from the incubation mixture. Figure 
9 shows SDS-PAGE of several combination experiments. The His-bind resin 
specifically recovered CTLA- 9, lanes 3, 4, 8, 9). 
When CTLA-
could be seen, indicating that these proteins were conjugated with CTLA-  (lanes 2, 
7). Western blot analysis using an anti-cathepsin L antibody clearly showed that 
among these proteins, the protein with a molecular weight of 24,000 was cathepsin L 
(lanes 2, 12). The lack of a band corresponding to cathepsin L in the incubation with 
the CTLA- -  was conjugated with cathepsin 
L by disulfide bonding (lanes 5, 10). Furthermore, the lack of a similar band was also 
observed in the incubation of CTLA-  with cathepsin L lacking an active site 
cysteine residue (lanes 6, 11). The CTLA-
heterogeneous molecular form in SDS-PAGE without 2-mercaptoethanol (lanes 7, 
13). To ascertain whether the CTLA- complex retains its enzyme 
activity or not, the cathepsin L activity of the isolated complex was continuously 
measured (Fig. 10). The complex did not exhibit enzyme activity even in the acidic 
condition (pH 5.5). After dissociation of the complex by treatment with DTT, 
significant and pH dependent cathepsin L activities were measured. 
Figure 9. Isolation of the CTLA- cathepsin L complex. SDS-PAGE using 12% 
polyacrylamide gels was performed with (lanes 1  6, 12) or without (lanes 7  11, 
13) 2-mercaptoethanol. Proteins were stained with silver nitrate reagent (lanes 1 
11). Proteins immunoreactive to the anti-cathepsin L antibody were visualized (lanes 
12, 13). Lane 1, protein molecular weight standards; lanes 2, 7, 12, 13, CTLA-
cathepsin L; lanes 3, 8, CTLA- cathepsin L: lanes 5, 10, CTLA-
(C75S)/ cathepsin L; lanes 6, 11, CTLA-  cathepsin L (E-64 treated).  
Figure 10: Progress curves for the cathepsin L activity of the CTLA-
 The progress curves were continuously monitored. The 
arrow indicates the time when 10 mM DTT was added to the reaction mixture. 
3.4. Identification of the CTLA-2 / cathepsin L, CTLA-2 / cathepsin C 
complexes conjugated with a disulfide bond from the tissue
Cathepsin L is a cysteine protease that has an essential cysteine residue at 
the active site. CTLA-
disulfide form and is engaged in its inhibitory potency (Deshapriya et al., 2010). As 
described above, the recombinant CTLA-
in vitro and CTLA- -like cysteine protease by oxidizing the 
active thiol residue of the enzyme with its own thiol residue. Therefore, we attempted 
to detect the CTLA- epsin L complex conjugated with a disulfide bond in vivo. 
The proteins recovered from Co-IP were subjected to SDS-PAGE with or without 2-
mercaptoethanol in the loading buffer and analyzed by western blotting using anti-
cathepsin L Ab and anti-CTLA- hen probed with anti-cathepsin L Ab (Fig. 11, 
lanes 1 - 3), a major band corresponding to cathepsin L was detected in the 
presence of 2-mercaptoethanol (lane 1). Three additional bands with higher 
molecular weights were detected in the absence of 2-mercaptoethanol (lane 3). 
Stripping and re-probing of the membrane with anti-CTLA-  6) led to 
the appearance of a protein band that corresponded to the molecular weight of the 
complex (lane 6), which suggested that one of the additional bands was the CTLA-
applied to the sample for cathepsin C. A similar band pattern to that of cathepsin L 
was also detected, which suggested that cathepsin C was also conjugated with 
CTLA- by disulfide bonding (Fig.12).  
Figure 11. Isolation of the CTLA-2 /cathepsin L complex conjugated with 
disulfide bonds from tissue.  A 10 dpc mouse uterus extract was subjected to Co-
IP using Anti-CTLA-  coupled beads, as shown in figure 5. The recovered proteins 
were subjected to 12% SDS-PAGE with (lanes 1, 2, 4, and 5) or without (lanes 3 and 
6) 2-mercaptoethanol. Proteins immunoreactive to the anti-cathepsin L (lanes 1, 2, 
and 3) and anti-CTLA-  (lanes 4, 5, and 6). 
Figure 12. Isolation of the CTLA-2 /cathepsin C complex conjugated with 
disulfide bonds from tissue.  A 10 dpc mouse uterus extract was subjected to Co-
IP using Anti-CTLA-  coupled beads, as shown in figure 5. The recovered proteins 
were subjected to 12% SDS-PAGE with (lanes 1, 2, 4, and 5) or without (lanes 3 and 
6) 2-mercaptoethanol. Proteins immunoreactive to the anti-cathepsin C (lanes 1, 2, 
and 3) and anti-CTLA-  (lanes 4, 5, and 6). 
3.5. CTLA- cathepsin C in cells 
We attempted to detect the inhibitory activity of recombinant CTLA-
purified mouse cathepsin C (R&D systems) using Gly-Arg-AMC as the substrate, 
and found no inhibitory activity up to 1 µM of CTLA-
switched to the simple cell-based fluorescence assay, which was designed to 
determine the activity of cathepsin C in live cells. Cos-7 cells were selected because 
they had low endogenous cathepsin C (Santilman, 2002). (Fig. 13A, B). As shown in 
Figure 13, green staining was strongly captured in cathepsin C-expressing Cos-7 
cells (Fig. 13C). The green signal was observed in about 74% of the cells expressing 
cathepsin C. This fluorescence labeling was significantly reduced in Cos-7 cells 
transfected with both cathepsin C and CTLA- 13E). These results 
demonstrated that CTLA-
Figure 13. A simple cell-based fluorescence assay for detecting cathepsin C 
activity. Fluorescence imaging of cells incubated with GF-AFC substrate (A, C, E). 
Nuclear stained with DAPI (B, D, F). Cos-7 cells (A, B). Cos-7 cells were transfected 
with pBApo. Cathepsin C (C, D). Cos-7 cells were transfected with pBApo.Cathepsin 
C and pFU.CTLA-
Study III 
Co-localization of CTLA- with cathepsin L, cathepsin C 
and TINAGL1 in HEK293T cells and in the mouse placenta
1. LITERATURE REVIEW 
CTLA-
(Campo et al., 1996), brain (Luziga et al., 2007), eye (Sugita et al., 2001) but little is 
known regarding the cellular expression and physiological function of CTLA-2
tissues and organs. Luziga et al (2007) reported the expression pattern of CTLA-
mRNA in the mouse brain by in situ hybridization, demonstrating that the mRNA is 
preferentially enriched within various neuronal populations. That expression pattern 
suggests that CTLA-  may have some roles related to memory and brain diseases.  
At the cell level, CTLA- localized in dendritic and axonal 
compartments and to a lesser extent in neuronal cell bodies (Luziga et al.,  2007). 
Similarly, strong staining was detected in basal dendrites of pyramidal neurons 
radiating through the stratum radiatum but was faint in pyramidal cell bodies. It can 
be hypothesised that CTLA-  protein is synthesized in neuron cell bodies but is 
secreted to dendrites where it might be playing a role in regulating neuronal function. 
CTLA-2  mRNA was mainly observed by Northern blot analysis in placenta and 
uterus and to a lesser extent in the lungs (Campo et al., 1996). CTLA-2  mRNA has 
also been demonstrated in mouse uterus during early pregnancy (Cheon et al., 
2004). Interestingly, three proteins that interact with CTLA-2  present in placenta as 
well. Cathepsin L is shown to be present in large amounts in the placenta, six times 
more than adult kidney and liver (Hamilton et al., 1991). Two forms of cathepsin L, 
pro and matureL, both exist in the mouse placenta. Giant cells and 
spongiotrophoblast were identified to synthesize and secrete procathepsin L. The 
large amount of cathepsin L in placenta may involve with defined function of tissue 
invasion in the embryonic developmental process. 
Cathepsin C is a cysteine protease involved in the processing of lysosomal 
cathepsins and the degradation of the intracellular protein (Methot et al., 2007). 
Cathespsin C performs important functions in many physiological and pathological 
progresses. However, its function is best characterized in the immune system.  
Cathepsin C transcript and protein both have been detected in placenta (Rao et al., 
1997; Menkhorst et al., 2012). Both pro and mature forms of cathepsin C were 
observed in the decidua region of placenta. It is believed to play an important role in 
the implantation and placentation process. 
The third protein - TINGAL1- interestingly also presents in the placenta. 
TINAGL1 is known as a matricellular protein that homologous to cathepsin B. 
However, physiological function and localization of TINAGL1 are still not clearly 
understood. In gestation, TINAGL1 has been expressed in extra-embryonic tissue 
and plays a physical and physiological role in embryo development at 
postimplantaion (Igarashi et al., 2009; Li et al., 2007). 
Taken together all these data, we hypothesized that CTLA-2  may associate 
with its interactive proteins to perform some physiological functions in placenta. In 
this chapter, information on the distribution of CTLA-2  in the placenta is presented. 
The co-localizations of CTLA-2  and three interactive proteins have been examined.  
2. MATERIAL AND METHODS 
Expression constructs, cell culture and transfection  
Full-length of CTLA- , Cathepsin L, Cathepsin C and TINAGL1 were cloned 
into -hlgG2-Fc1) to generate pFU-F.CTLA2 
and pFU-F.CtsL, pFU-F.CtsC, pFU-F.TINAGL. 
  HEK293T (Human Embryonic Kidney) cells were cultured in DMEM (Wako) 
supplemented with 10% fetal bovine serum at 370C in a humidified atmosphere 
containing 5% CO2. DNA transfection of HEK293 cells was carried out at 60% 
80% confluent using ScreenFect A (Wako) 
Immunofluorescence staining and imaging of HEK293T cells line 
To detect the co-localization of CTLA-  cathepsin L/cathepsin C/ 
TINAGL1 from the transfected cells, HEK293T cells plated on round coverslip and 
co-transfected with pFU-F.CTLA-2 and pFU-F.CtsL;  pFU-F.CTLA-2 and pFU-
F.CtsC ; pFU-F.CTLA-2 and pFU-F.TINAGL-1. After 24h, cells were washed twice 
with PBS and fixed in 4% paraformaldehyde. Cells were permeabilized with 0.2% 
Triton X-100 and further incubated with blocking buffer (PBS containing 1% Bovine 
Serum Albumin, 0.1% Triton x-100) for 30 minutes at RT to block non  specific 
binding. The cells were incubated with mixture of two diluted primary antibodies from 
difference host species (diluted in blocking buffer) for 24 hours in humid chamber at 
4ºC. For negative control, cells were incubated with normal serums of the same 
species and same concentration as the primary antibodies. After incubation, the cells 
were washed (3 x 5 min) by PBS/ 0.1% Triton X-100, followed by incubation for 1 
hour at RT with a mixture of Alexa Fluor 594 conjugated Goat anti-chicken IgY and 
Alexa Fluor 488 conjugated Donkey anti-Rabbit IgG. At the end of incubation, the 
cells were washed (3 x 5 mins) in PBS/0.2% Triton X-100 and further incubated for 2 
mins with DAPI. Finally, coverslip were washed by PBS and mounted. 
Immunofluorescence labeling and imaging of tissue 
Immunofluorescence analysis was performed to determine the distribution 
profile of CTLA-
Kyudo (Saga, Japan) and used for the experiment at 8, 9, 10, 14 and 17 days post 
coitum (dpc). Placenta tissues were snap-frozen, then sectioned at 15-µm and 
mounted onto silane-coated slides and stored at -80ºC until use. After thawing at RT, 
sections were rehydrated in PBS for 10 min and fixed in 4% paraformaldehyde. The 
sections were then treated with PBS containing 1% BSA and 5% of donkey serum to 
block non-specific binding. Sections were incubated in rabbit anti-CTLA-  for 
24h in a humid chamber at 4ºC for the primary Ab reaction. Sections incubated in 
normal rabbit serum with the same concentration as the primary Abs were used as 
negative controls. After washing with PBS (5 min x 3 times), followed by incubation 
for 1h at RT with Alexa Fluor 488 conjugated donkey anti-rabbit IgG, washing in PBS/ 
0.1 Triton X-100 (3 x 5 min) and a further incubation for 2 min with DAPI, sections 
were again washed with PBS and mounting. The expression of cathepsin L was 
examined in 10 dpc and 12 dpc mouse uteri with chicken anti-cathepsin L IgY and 
Alexa Fluor 594 conjugated goat anti-chicken IgY.  
To confirm the co-localization of CTLA-
C/TINAGL1 in vivo, double immunostaining was performed on mouse uterus 
sections. The initial steps used to process tissues were the same as for single 
labeling. However, the sections were incubated with a mixture of diluted primary Abs: 
rabbit anti-CTLA- -cathepsin L IgY; chicken anti-CTLA-
IgY/rabbit anti-cathepsin C IgG; chicken anti-CTLA- -TINAGL1 IgG. 
In the second Ab reaction, sections were treated with a mixture of Alexa Fluor 594 
conjugated goat anti-chicken IgY and Alexa Fluor 488 conjugated donkey anti-rabbit 
IgG. Immunolabeling was analyzed using the BZ-9000E HS all-in-one Fluorescence 
Microscope (KEYENCE, Japan). 
3. RESULTS 
3.1. Expression of Cathepsin L, TINAGL1 and CTLA- the co-transfected 
HEK293T cells 
 Further confirmation of the interaction between Cathepsin L, TINAGL1 and 
CTLA- T cells 
co-transfected with pFU-F.CTLA-2 + pFU-F.CtsL and pFU-F.CTLA-2 + pFU-
F.TINAGL vectors and stained cells were visualized by fluorescence microscopy 
(Fig.14). The results showed that CTLA- (Fig.14A; green) and Cathepsin L 
(Fig.14A; red) were uniformly distributed throughout the cells. Similarly, CTLA-
(Fig.14B; red) and TINAGL1 (Fig.14B; green) can also be detected throughout the 
transfected cells. When the images were overlaid (Fig.14A & 14B; yellow), both 
Cathepsin L and TINAGL1 overlapped with CTLA-
and TINAGL1 interact with CTLA-
3.2. Distribution of CTLA- in the mouse placenta at various 
developmental stages
The distribution pattern of CTLA-
transversal sections of the whole pregnant mouse uterus and placenta in the five 
difference stages of pregnancy. Before carrying out the immunofluorescence staining, 
Hematoxylin and Eosin stained sections has been used to identify each region (Fig. 
15A). By immunofluorescence labeling, CTLA- specific 
localization, it was strongly detected in some placental regions, but was absent in 
others (Fig. 15B). At 8 and 9 dpc, the well-developed decidua (WD) and myometrium 
(MM) were highly stained by the anti-CTLA-
endometrium (ED) was weakly stained. CTLA-
decidua basalis (DB) and metrial gland (MG), but not in the placental labyrinth (PL) 
at 10 dpc. By 14 and 17 dpc, CTLA-
Almost blank labeling was observed when the anti-CTLA-
with normal rabbit serum. The specific spatial expression pattern and strong 
induction of expression suggested an essential role for CTLA-
development of a functional mouse placenta. The presence of cathepsin L in the 
placenta was then evaluated. The cathepsin L protein was highly expressed in the 
whole placenta including the labyrinth at 10 and 12 dpc (Fig. 15C). The signal was 
also observed in the PL and embryo, indicating that cathepsin L was expressed 
ubiquitously.  
3.3. Co-localization of cathepsin L, cathepsin C, and TINAGL1 with CTLA-
the mouse placenta. 
The co-localization of cathepsin L, cathepsin C, and TINAGL1 with CTLA-
was evaluated in the placenta using double-immunofluorescence labeling. Figure 16 
showed that cathepsin L was expressed ubiquitously in the uterus, whereas CTLA-
ere only detected in certain regions of the placenta. 
As shown in Figure 16A, cathepsin L (red) was clearly observed in the whole 10 dpc 
uterus including the embryonic region, while the CTLA-
in the embryo and PL. This result suggested that CTLA- -localized with 
cathepsin L in the DB and MG of the placenta. Co-localization was absent in other 
regions. As shown in Figure 16B, staining for cathepsin C (green) in the placenta at 
10 dpc was weakly detected in the labyrinth, DB and MG. The co-localization of 
CTLA-
previously reported to be expressed in the post-implantation uterus. Therefore, 
double immunofluorescence analysis was carried out in 8 dpc uterus to identify the 
co-localization of CTLA- 16C showed that the expression 
patterns of CTLA-
dpc). They were strongly detected in the WD and MM regions (yellow). Weak co-
expression was observed in the ED and no labeling was detected in the immature 
placental labyrinth.  
Figure 14. Co-localization of Cathepsin L, Cathepsin C, TINAGL1 with CTLA-2
in HEK293T cells. (A) CTLA-2  (green) and Cathepsin L (red)  proteins were 
visualized by double-immunostaining. The overlay image shows region of signal 
overlap. (B) HEK293T cells were co-transfected with expression vectors for CTLA-2
and TINAGL1. Protein expression was detected using double-immunostaining. The 
two figures [CTLA-2  (red) and TINAGL1 (green) ] have been merged (yellow). 
Figure 15. Distribution of CTLA- in the mouse placenta at 
various placentation periods. A) Hematoxylin and Eosin staining was performed 
for the mouse uterus (8-10 dpc) and mouse placenta (14 dpc). Immunofluorescence 
labeling was performed for the mouse uterus (8-10 dpc) and mouse placenta (14-17 
dpc). B) Immunoreactivity for CTLA-
9 dpc (9D), 10 dpc (10D), 14 dpc (14D), 17 dpc (17D). Neg; negative control stained 
with normal rabbit serum (8D). C) Immunoreactivity for cathepsin L (red) at 10 dpc 
(10D), 12 dpc (12D). Neg; negative control stained with normal chicken IGY (10D). 
Immature labyrinth (IL), placental labyrinth (PL), spongiotrophoblast (SP), decidua 
basalis (DB), well-development decidua (WD), endometrium (ED), metrial gland 
(MG), and myometrium (MM).  
Figure 16. Co-localization of cathepsin L (A), cathepsin C (B), and TINAGL1 (C) 
with CTLA-  mouse placenta. (A) The immunoreactivities of 
CTLA- -CTLA-
-Cathepsin L IgY) were mixed and used as primary Ab. (B) 
CTLA- vities were detected. Two Abs 
(chicken anti- CTLA- -Cathepsin C IgG) were mixed and used 
as primary Ab. A mixture of normal chicken IGY and normal rabbit serum was used 
as the negative control (Neg 1&2). C) CTLA- reen,) 
immunoreactivities were observed. Two Abs (chicken anti- CTLA-
anti-TINAGL1 IgG) were mixed and used as primary Ab. Normal rabbit serum was 
used as a negative control (Neg).
Discussion 
Interaction between CTLA-
Yeast two-hybrid analysis led to the discovery of the interaction between 
CTLA-
which recombinant CTLA- n L- like cysteine 
proteinase (Kurata, 2003). In the present study, the CTLA-
was isolated from pregnant uteri, thereby confirming that CTLA-
cathepsin L under physiological conditions. Results of this study were compared with 
the finding of the previous work in which CTLA-
from day 7 pregnant uteri extracts but not in 10 pregnant uteri (Campo, 1996). 
this study.  
CTLA-  contains one cysteine residue, C75, in the sequence, rendering the 
formation of a dimer by an intermolecular disulfide bond between the monomers. In 
the present study, CTLA-  such a dimer in vitro and 
also possibly under physiological conditions. The dimeric form of CTLA-
been reported, but this was a non-covalent complex of the monomer (Delaria et al.; 
1994). The dimeric form of CTLA-  form by treatment 
with DTT, completely lost its inhibitory activity. DTT is known to be a strong reducing 
reagent that reduces disulfides to dithiols and then maintains these thiols in a 
reduced state. Therefore, our results indicate that the CTLA-
thiol residue was not inhibitory. By removing DTT from the buffer, part of the 
monomer reassociated to form a dimer, which suggests that the monomer and dimer 
forms of CTLA-  inhibitory 
potency of the CTLA-2  dimer by oxidization 
with glutathione disulfide (GSSG). These results imply that the cysteine residue of 
CTLA-  engaged in the inhibitory process. This 
result is in accordance with previous findings in which the cysteine residue (C75) 
was shown to be one of the essential amino acids of CTLA-
potency (Deshapriya et al.; 2010). Moreover, present attempts to isolate the CTLA-
 that, in the process of inhibition, CTLA-
may be covalently bound to the catalytic subunit of cathepsin L via the cysteine 
residue (C75). The catalytic cysteine residue (C25E) of cathepsin L is located close 
to the cysteine residue of CTLA- as been suggested by molecular 
modeling analysis of the CTLA- (Deshapriya et al.; 2010). 
CTLA-  cathepsin L-like cysteine protease by oxidizing the active thiol 
residue of the enzyme with its own thiol residue. Successful isolation of CTLA-
, 
suggesting this may occur in vivo. This result suggested that in vivo CTLA-
inhibit cathepsin L-like cysteine protease by oxidizing the active thiol residue of the 
enzyme with its own thiol residue. 
Interaction between CTLA-
Cathepsin C is a lysosomal cysteine protease that sequentially removes 
dipeptides from the unsubstituted N-terminus of target proteins with broad specificity 
(Turk et al.; 1968). This study demonstrated for the first time that CTLA-
with and is a potential endogenous inhibitor of cathepsin C. The isolation of the 
CTLA-
of the interaction in physiogical conditions.  
The simple cell-based fluorescence assay also revealed that the GF-AFC
substrate entered intact cells and was cleaved by cathepsin C to release AFC, 
leading to an increase in fluorescence intensity. The presence of CTLA-
significant reduction in the intensity of labeling in cathepsin C-expressing cells. This 
suggests that CTLA- in vivo. Inhibitory activity 
was not observed in vitro using purified cathepsin C, similar to cystatin F, a cathepsin 
C-directed protease inhibitor. Cystatin F was previously shown to be unable to inhibit 
cathepsin C in vitro (Langerholc et al.; 2005), but suppressed the activity of 
endogenous cathepsin C in vivo (Hamilton et al.; 2008). We also attempted to 




Although TINAGL1 is not a peptidase, it has been identified as a protein 
homologous to cysteine proteases such as cathepsin L, B, and C 
(http://merops.sanger.ac.uk). The C-terminal of TINAGL1 was shown to be 
homologous to cathepsin B, but the active cysteine residue was replaced with a 
serine residue, which resulted in a proteolytically inactive protein (Bromme et al.; 
2000). The structure and biological functions of this protein are still not well 
characterized. TINAGL1 is a matricellular protein that interacts with both structural 
proteins and cell surface receptors (Bromme et al.;, 2000). Using the yeast system, a 
strong interaction was observed between CTLA- and TINAGL1. However, it was 
not possible to isolate the CTLA-2 /TINAGL1 complex from mouse tissue by Co-IP. 
This was due to molecular weight of TINAGL1 being very close to immunoglobulin G 
(IgG; ~53kDa), and the difficulties associated with distinguishing between the target 
protein (TINAGL1) and IgG leaking from the beads. TINAGL1 is a secretory protein 
(Wex et al.; 2001). Similarly, as described above part of CTLA-
cells. Thus, pull-down assay was used to isolate the CTLA-2 /TINAGL1 complex 
from the culture medium of TINAGL1-expressing cells suggesting that the interaction 
between CTLA- TINAGL1 occurs in vivo.  
Location of CTLA-
A previous study detected the expression of the CTLA-
during late pregnancy (Campo et al.; 1996). However, the tissue locations and 
physiological functions of CTLA-
Immunofluorescence showed that CTLA-
side including the DB, MG, and MM layers, but was not observed on the embryonic 
side at different developmental stages from day 8 to day 17. Its isoform, the CTLA-
protein, was also reported to be expressed in the pregnant uterus (Campo et al.; 
1996). Thus, the cross-reactivity can happen between anti- CTLA- A-
-
between day 4 to day 9 but was not observed on day 10. These findings indicate that 
from day 10, immunoreactivity specific detected CTLA-
placenta.  
Besides, trophoblast-specific protein (TPBP), which is expressed in the 
placenta, is homologous to CTLA- . Thus, the cross-reactivity can happen between 
anti- CTLA-
the spongiotrophoblast layer (Deussing et al.; 2013) and the immunoreactivity of 
CTLA-
layer 
The expression of the three CTLA-
cathepsin C, and TINAGL1, has been reported previously in the placenta (Igarashi et 
al.; 2009; Hamilton et al.; 1991; Menkhost et al.; 2012). The results of the present 
study revealed the different expression profiles of cathepsin L, cathepsin C, and 
TINAGL1 in the mouse placenta. Results of this study also clearly demonstrate co-
localization of CTLA-
Co-localization of CTLA-
Cathepsin L is shown to be present in large amounts in the placenta, implying 
that Cathepsin L plays important role in the placenta (Hamilton et al.; 1991). The 
present study also shows that cathepsin L is ubiquitously expressed in the placenta 
and co-localizes with CTLA-
for the proteolytic processing of extracellular matrices, cellular invasion and 
migration (Hamilton et al.;1991; Krischke et al.; 2012) and a part of it has also been 
reported to be secreted in the placenta (Hamilton et al.;1991), and regulation of 
trophoblast invasion is an important process for placental formation. Taking these 
data altogether, it is stipulated that CTLA-
be involved in the decidualization reaction and normal placental formation. Placenta-
specific cysteine peptidases, which are referred to as cathepsin L-related proteins 
(CLRPs) due to their high degree of similarity to cathepsin L (Deusing et al.; 2009), 
can be inhibited by CTLA- -
side, whereas CLPRs was detected on the embryonic side such as the labyrinth and 
spongiotrophoblast (Deusing et al.; 2009). This implies that CTLA-
control the activities of CLRPs.  
Co-localization of CTLA-
The expression profile of cathepsin C in the placenta differed from that of 
cathepsin L. Cathepsin C was previously shown to be weakly expressed in the 
placenta (Menkhost et al.; 2012). In this study, the co-expression signal of cathepsin 
C and CTLA-  detected in the DB and MG. CTLA-
activity as an inhibitor in these regions. Cathepsin C plays an important role in 
various physiological and pathological progresses (Turk et al.; 2012) and it is 
required for the activation of serine proteases from granules of immune and 
inflammatory cells. Granzymes A and B, two targets of cathepsin C, are important 
factors that mediate apoptotic pathways (Turk et al.; 2012; Pham CTN et al.; 1999). 
In addition to the placenta, CTLA- d in the brain and eyes (Luziga et 
al.; 2007, 2008). All these organs have been identified as immune-privileged sites, in 
which immune-tolerance mechanisms that operate to protect tissues from immune-
mediated damage are known to be established (Mochizuki et al.; 2010). In the 
developing placenta, abundant numbers of "uterine natural killer cells" are existed at 
the regions of DB and MG. These cells possess granzyme B and have a possibility to 
secrete against the fetal tissue (Parr et al.; 1990). Taken together, these findings 
suggest that CTLA-
involved in the processes that protect the embryo from the maternal immune system. 
Co-localization of CTLA-
The expression of TINAGL1 in the decidua was previously demonstrated to 
support post-implantation embryonic development (Tajiri et al.; 2010). Furthermore, 
TINAGL1 has been shown to promote endothelial cell adhesion (Li et al.; 2007), and 
is essential to angiogenesis in developing zebrafish embryos (Brown, 2010). Since 
high levels of TINAGL1 was detected in the placenta from day 6 to day 8 (Li et al.; 
2007), immunohistochemical studies were performed in 8 dpc uteri to examine the 
co-localization of CTLA- -
TINAGL1 were similar in 8 dpc-mouse uteri. Therefore, we hypothesized that CTLA-
migration during early post-implantation periods.  
Conclusion 
This is the first study to provide direct evidence for the interaction between 
CTLA- in vivo. Novel interactions between CTLA-
cathepsin C and TINAGL1 were also demonstrated. Results of this study suggest 
that CTLA- in vivo. Their 
interactions in the placenta suggest important function of these proteins in embryo 
implantation and development. More research is needed to help better understand 
the role of CTLA-
REFFERENCES  
[1] Adkison, A.M., Raptis, S.Z., Kelley, D.G., Pham, C.T.N. Dipeptidyl peptidase I 
activates neutrophil-derived serine proteases and regulates the development 
of acute experimental arthritis. The J.Clin.Invest. 2010; 109: pp. 363-371. 
[2] Barrett, A. J., Kirschke, H. In:  
Lorand. L, Editor. Methods in Enzymology. Academic Press, New York. 1981; 
vol 80: pp. 535-561. 
[3] Barrett, A. J., Woessner. J.FJ. In: Rawlings. N.D. editor. Handbook of 
Proteolytic Enzymes. Academic Press, London. 1998; pp. 235-254 
[4] Berti, P.J., Storer, A.C. Alignment/phylogeny of the papain superfamily of 
cysteine proteases. J. Mol. Biol. 1995; 246: pp. 273-283 
[5] Bromme, N.C., Wex, T., Wex, H., Levy, B., Lipyansky, A., Bromme, D. Cloning, 
characterization, and expression of the human TINAGL1 gene encoding a 
novel extracellular matrix protein. Biochem. Bioph. Res. Co. 2000; 271:474-
480.
[6] Brömme, D., Wilson, S. Role of cysteine cathepsins in extracellular proteolysis. 
In: Parks WC, Mecham RP, editors. Extracellular matrix degradation. Springer-
Verlag; 2011; pp. 23-44.
[7] Brown, L.J., Alawoki, M., Crawford, M.E., Reida, T., Sears, A. Lipocalin-7 Is a 
Matricellular Regulator of Angiogenesis. PLoS ONE. 2010; 5(11): 1-11.
[8] Bui, T.T.N., Takeshita, Y., Yamamoto, M., Yamamoto, Y. Studies of inhibitory 
mechanisms of propeptide-like cysteine protease inhibitors. Enzyme res. 2014.
[9] Bui, T.T.N., Luziga, C., Kusakabe, K.T., Yamamoto, M., Yamamoto, Y. 
Identification and characterization of the interactive proteins with Cytotoxic T-
lymphocyte antigen-
[10] Camenisch, G., Tini, M., Chilov, D., Kvietikove, I., Srinivas, V., Caro, J., 
Spielmann, P., Wenger, R.H. General applicability of chicken egg yolk 
antibodies: the performance of IgY immunoglobulins raised against the 
hypoxia- FASEB J. 1999; 13(1): pp. 13-81.
[11] Campo, M.A., Rice, E.J., Kasik, J.W. There is an increase in expression of the 
cytotoxic T-lymphocyte antigen-
Gynecol. 1996; 174(5): pp. 1605-1607.
[12] Carmona, E., Dufour, E., Plouffe, C., Takebe, S., Mason, P., Mort, J.S., 
Menard, R. Potency and selectivity of the cathepsin L propeptide as an 
inhibitor of cysteine proteases. Biochemistry. 1996; 35: pp. 8149-8157. 
[13] Cheon, Y.P., DeMayo, F.J., Bagchi, M.K., Bagchi, I.C. Induction of cytotoxic 
T-lymphocyte antigen-
regulator of embryo implantation. J. Biol. Chem. 2004; 279(11): pp. 10357-
10363.
[14] Chen, Y., Plouffe, C., Menard, R., Storer, A.C. Delineating functionally 
important regions and residues in the cathepsin B propeptide for inhibitory 
activity. FEBS Lett. 1996; 39: pp. 24-26. 
[15] Chowdhury, S.F., Sivaraman, J., Wang, J., Devanathan, G., Lachance, P., Qi, 
H., Ménard, R., Lefebvre, J., Konishi, Y., Cygler, M., Sulea, T., Purisima, E.O. 
Design of noncovalent inhibitors of human cathepsin L. from the 96-residue 
proregion to optimized tripeptides. Journal of Medical Chemistry. 2002; 45: pp. 
5321-5329. 
[16] Chien, C.T., Bartel, P.L., Sternlanz, R., Fields, S. Proc. Natl. Acad. Sci. USA. 
1991; 88: pp. 9578-9582. 
[17] Coulombe, R. P., Grochuiski, J., Sivarman, R., Ménard, J., Mort, S.,Cygler, M. 
Structure of human procathepsin L reveals the molecular basis of inhibition by 
the prosegment. EMBO Journal 1996; 15(20): pp. 5492-550.
[18] Cygler, M., Mort, J.S. Proregion structure of members of the papain 
superfamily. Mode of inhibition of enzymatic activity. Biochimie. 1997; 79: pp. 
645-652 
[19] Delaria, K., Fiorentino,  L., Wallace, L., Tamburini, P., Brownell, E., Muller, D. 
Inhibition of cathepsin L-like cysteine proteases by cytotoxic T-lymphocyte 
antigen- pp. 25172-25177.
[20] Denizot, V., Brunet, J.F., Roustan, P., Harper, K., Suzan, M., Luciani, M.F., 
Mattei, M.G.P., Golstein, P. Novel structures CTLA- -
expressed in mouse activated T cells and mast cells and homologous to 
cysteine proteinase proregions. Eur. J. Immunol. 1989; 19: pp. 631-635. 
[21] Deshapriya. R.M.C., Yuhashi, S., Usui, M., Kageyama, T., Yamamoto, Y. 
Identification of essential residues of CTLA-
Biochem. 2010; 147(3): pp. 393-404. 
[22] Deshapriya, R. M. C., Takeuchi, A., Shirao, K., Isa, K., Watabe, S., Murakami, 
M., Tsujimura, H., Yamamoto, Y. Drosophila CTLA-2-like protein (D/CTLA-2) 
inhibits cysteine proteinase 1 (CP1), a cathepsin L-like enzyme. Zoological 
Science. 2007; 24(1): pp. 21-30. 
[23] Deussing, J. Placenta-specific Cathepsins. In: Barrett AJ, Rawlings ND, 
Woessner JF, editors. Handbook of Proteolytic Enzymes. Volume.1. 2nd 
edition.  Elsevier Academic Press; 2012. p. 1945-1851.  
[24] Deussing, J., Koudio, M., Rehman, M., Werber, I., Schwinde, A., Peter, C. 
Identification and characterization of a dense cluster of placenta-specific 
cysteine peptidase genes and related genes on mouse chromosome 13. 
Genomics. 2012; 79: pp.  225-240.
[25] Guo, Y.L., Kurz, U., Schultz, J.E., Lim, C.C., Wiederanders, B., Schilling, K. 
The a1/2 helical backbone of the prodomains define the intrinsic inhibitory 
specificity in the cathepsin L- like cysteine protease subfamily. FEBS Lett. 
2000; 469: pp.  203-207. 
[26] Fabien, L., Brömme, D. Human and Parasitic Papain-Like Cysteine 
in Inhibitor Design. Chem. Rev. 2002; 102 (12): pp: 4459 4488. 
[27] Fields. S., Song.O. Nature. 1989; 340: pp. 245-246. 
[28] Hamilton, G., Colbert, J., Schuettelkopt, A., Watts, C. Cystatin F is a 
Cathepsin C-directed protease inhibitor regulated by proteolysis. The EMBO J. 
2008; 27: pp. 499-508.
[29] Hamilton, R., Bruns, K., Delgado, M., Shim, J., Fang, Y., Denhardt, D., Nilsen-
Hamilton M. Developmental expression of Cathepsin L and c-rasHa in the 
mouse placenta. Mol. Reprod. Dev. 1991; 30: pp. 285-292. 
[30]  Igarashi,T., Tajiri, Y., Sakurai, M., Sato, E., Li, D., Mukai, K., Suematsu, M., 
Fukui, E., Yoshizawa, M., Matsumoto, H. Tubulointerstitial nephritis antigen-
like 1 is expressed in extraembryonic tissue and interacts with Laminin 1 in the 
Reichert Membrane at postimplantation in the Mouse. Biol. Reprod. 2009; 80: 
pp. 948-955.
[31] Irischke, H. Cathepsin L. In: Barrett AJ, Rawlings ND, Woessner JF, editors. 
Handbook of Proteolytic Enzymes. Volume.1. 2nd edition.  Elsevier Academic 
Press; 2012. pp. 1808-1817.
[32] Katunuma, N., Kominami, N. Structure, properties, mechanisms, and assays 
of cysteine protease inhibitors: cystatins and E-64 derivatives. In: Methods in 
Enzymology vol. 251, L. Packer, Ed., Academic Press, San Diego, 1995. pp. 
382-397 
[33] Kurata, M., Hirata, M., Watabe, D., Miyake, M., Takahashi, S.Y., Yamamoto, 
Y. Expression, purification, and inhibitory activities of mouse cytotoxic T-
lymphocyte antigen-  pp. 119-125. 
[34] Kurata, M., Yamamoto, Y., Watabe, S., Makino, Y., Ogawa, K., and 
Takahashi, S.Y. Bombyx cysteine proteinase inhibitor (BCPI) homologous to 
propeptide regions of cysteine proteinases is a strong, selective inhibitor of 
cathepsin L-like cysteine proteinases. J. Biochem. 2001; 130: pp. 857-863.
[35] Langerholc, T., Zavasnik-Bergant, V., Turk, V., Abrahamson, M., Kos, J. 
Inhibitory properties of cystation F and its colocalization in U937 promonocyte 
cells. FEBS J. 2005; 271: pp. 1535-1545.
[36] Lecaille, F., Kaleta, J., and Bromme, D. Human and parasitic-like cysteine 
proteases: their role in physiology and pathology and recent development in 
inhibitor design. Chem. Rev. 2002; 102: pp. 4459-4488.
[37] Li, D., Mukai, K., Suzuki, T., Suzuki, R., Yamashita, S., Mitani, F., Suematsu, 
M. Adrenocortical zonation factor 1 is a novel matricellular protein promoting 
integrin-mediated adhesion of adrenocortical and vascular smooth muscle 
cells. FEBS J. 2007; 274: pp. 2506 2522.
[38] Luziga, C., Nakamura, O., Deshapriya, R.M.C., Usui, M., Miyaji, M., Wakimoto, 
M., Wada, N., Yamamoto, Y. Expression mapping of cytotoxic T-lymphocyte 
antigen-2 alpha gene transcripts in mouse brain. Histochem. Cell Biol. 2007; 
127(6): pp. 569-579.
[39]  Luziga, C., Nakamura, O., Deshapriya, R.M.C., Usui, M., Miyaji, M., 
Wakimoto, M., Wada, N., Mbassa, G., Yamamoto, Y. Dendritic and axonal 
localization of cytotoxic T-lymphocyte antigen-2 alpha protein in mouse brain. 
Brain Res. 2008; 1204: pp. 40-52. 
[40] Menkhost, E.M., Lane, N., Winship, A.L., Li, P., Yap, J. Decidual- secreted 
factors alter invasive trophoblast membrane and secreted protein implying a 
role for decidua cell regulation of placentation. PLoS ONE. 2012; 7(2): pp. 1-11.
[41] Methot, N., Rubin, J., Guay, D., Beaulieu, C., Ethier, D. Inhibition of the 
activation of multiple Serin protease with Cathepsin C inhibitor requires 
sustained exposure to prevent pro-enzyme precessing. J. Biochem. 2007; 282: 
pp. 20836-20846. 
[42] Mochizuki, M. Regional immunity of the eye. Acta Ophthalmol. 2010; 88: pp. 
292-299. 
[43] Parr, E.L., Young, L.H., Parr, M.B., Young, J.D. Granulated metrial gland cells 
of pregnant mouse uterus are natural killer-like cells that contain perforin and 
serine esterases. J. Immunol. 1990; 145(7): pp. 2365-2372.
[44] Pham, C.T.N., Let, T.J. Dipeptidyl peptidase I is required for the processing 
and activation of  granzymes A and B in vivo. Proceeding of National Academy 
of Sciences; 1999 June 20; USA. 96(15): pp. 8627-8632. 
[45]  Reddy, V.Y., Zhang, Q.Y., Weiss, S.J. Pericellular mobilization of the tissue-
destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-
derived macrophages. Proc. Natl. Acad. Sci. 1995; 92: pp3849 3853. 
[47] Santilman, V., Jadot, M., Mainderme, F. Importance of the propeptide in the 
biosynthetic maturation of rat Cathepsin C. Eur. J. Cell Biol. 2002; 81: pp. 654-
663.
[48] Sugita, S., Yamada, Y., Horie, S., Nakamura, O., Futagami, Y., Yamamoto, Y., 
Yamagami, S., Mochizuki, M. Induction of T Regulatory Cells by Cytotoxic T-
Lymphocyte Antigen-  on Corneal Endothelial Cells. Invest. Ophthalmol. Vis. 
Sci. 2011; 52: pp. 2598-2605.
[49]  Sugita. S., Horie, S., Nakamura, O., Futagami, Y., Takase, H., Keino,H., 
Aburatani, H., Katunuma, N., Ishidoh, K., Yamamoto, Y., Mochizuki, M. Retinal 
pigment epithelium derived cytotoxic T lymphocyte antigen- -
producing T regulatory cells. J. Immunol. 2008; 181: pp. 7525-7536. 
[50] Sugita, S., Horie, S., Nakamura, O., Maruyama, K., Takase, H., Usui, Y., 
Takeuchi, M., Ishidoh, K., Koike, M., Uchiyama, Y., Peters, C., Yamamoto, Y., 
Mochizuki, M. Acquisition of T regulatory function in cathepsin L-inhibited T 
cells by eye-derived CTLA-2 during inflammatory conditions. J. Immunol. 2009; 
183: pp. 5013  5022. 
[51] Rao, N.V., Rao, G.V., Hoidal, J.R. Human Dipeptidyl peptidase I. J. Bichem. 
1997; 272: pp. 10260-10265. 
[52] Rawlings, N.D., Barrett, A.J. Families of Cysteine peptidases. Meth. Enzymol.  
1994; 244: pp. 461-486. 
[53] Takahashi, S., Zhao, X., Kageyama, T., Yamamoto, Y. Acid cysteine 
proteinase from the eggs of silkmoth, Bombyx mori: Tissue distribution 
developmental changes and the sites of synthesis for the enzyme. Insect 
Biochem. Molec. 1992; 22(4): pp. 369-377.
[54] Tao, K., Stearns, N.A., Dong, J., Wu, Q.-L., and Sahagian, G.G. The 
proregion of cathepsin L is required for proper folding, stability and ER exit. 
Arch.Biochem. Biophys. 1994;  311: pp. 19-27.
[55] Tajiri, Y., Igarashi, T., Li, D., Mukai, K., Suematsu, M., Fukui, F., Yoshizawa, 
M., Matsumoto, H. Tubulointerstitial Nephritis Antigen-Like 1 Is Expressed in 
the Uterus and Binds with Integrins in Decidualized Endometrium During 
Postimplantation in Mice. Biol. Reprod. 2010; 82: pp. 263-270.
[56] Thong,B., Pilling, J., Ainscow, Beri., Unitt, J. Development and validation of a 
simple Cell-based fluorescence assay for Dipeptidyl Peptidase 1 (DPP1) 
activity. J. Biomol. Screen. 2011; 16(1): pp. 36-43.
[57]  Turk, B., Turk, D., Dolenc, I., Turk, V. Dipeptidyl-Peptidase I. In: Barrett AJ, 
Rawlings ND, Woessner JF, editors. Handbook of Proteolytic Enzymes. 
Volume.1. 2nd edition.  Elsevier Academic Press; 2012. pp. 1968-1973.
[58] Turk, B., Dolenc, I., Turk, V., and Bieth, J.G. Kinetics of the pH induced 
activation of human cathepsin L. Biochemistry. 1993; 32: pp. 375-382.
[59] Turk, V., Stoka, V., Vasiljeva, O., Renko, M., Sun, T., Turk, B., Turk, D. 
Cysteine cathepsins: from structure, function and regulation to new frontiers. 
Biochimica et Biophysica Acta.  2012; 1824: pp. 68-88
[60] Wex, T., Lipyansky, A., Bromme, N.C., Wex, H., Guan, X.Q., Bromme, D. 
TINAGL1, a novel catalytically inactive cathepsin B-related protein with 
EGFdomains, is predominantly expressed in vascular smooth muscle cells. 
Biochemistry. 2001; 40: pp. 1350 1357.
[61] Wiederanders, B., Kaulmann, G., and Schilling, K. Function of propeptide 
parts in cysteine proteases Curr. Protein Pept. Sci. 2003; 4: pp. 309-326. 
[62]  Wiederanders, B. Structure-function relationship in class CA1 cysteine 
peptidase propeptides. Acta Biochim. Pol. 2003; 50: pp. 691-713. 
[63] Wakamatsu, N., Kominami, E., Takio, K., Katunuma, N. Three forms of thiol 
proteinase inhibitor from rat liver formed depending on the oxidation-reduction 
state of a sulfhydryl group. Journal of Biological Chemistry. 1984;  259(22): pp. 
13832-13838. 
[64] Yamamoto, Y., Kurata, M., Watabe, S., Murakami, R., and Takahashi, S.Y. 
Novel cysteine proteinase inhibitors homologous to the proregions of cysteine 
proteinases. Curr. Protein Pept. Sci. 2002; 3: pp. 231-238
[65] Yamamoto, Y., Watabe, S., Kageyama, T., and Takahashi, S.Y. Purification 
and characterization of Bombyx cysteine proteinase specific inhibitors from the 
hemolymph of Bombyx mori. Arch. Insect Biochem. Physiol. 1999; 41: pp. 119-
129
[66] Yamamoto, Y., Watabe, S., Kageyama, T., and Takahashi, S.Y. A Novel 
inhibitor protein for Bombyx cysteine proteinase is homolgous to propeptide 
regions of cysteine proteinases. FEBS Lett. 1999;  448: pp. 257-260 
[67] Zhang, L., Yun, H., Murray, F., Lu, R., Wang, L., Hook, V. Insel, P.A. 
Cytotoxic T lymphocyte antigen-2 alpha induces apoptosis of murine T-
lymphoma cells and cardiac fibroblasts and is regulated by cAMP/PKA. 
Cellular Signal. 2011; 23(10): pp. 1611-1616.
APPENDICES 
Appendix I: Localizaion of CTLA-  in the mouse placenta. 
Appendix II: 
Localization of cathepsin L in the mouse placenta 
Appendix III: 
Localization of cathepsin C in the mouse placenta 
Appendix IV: Detection the localization of CTLA-
Double immuno-staining using anti- CTLA- -LAMP1 (lysosome marker) 
Abs have been performed on HEK293T cells transfeted with CTLA-
seen in the figure appendix 4, CTLA-
A                                                    B                                               Overlay image                 
Appendix V: Detection the regulatory T cells in the mouse placenta. 
Previous studie shows that CTLA-
immunity in the eye. Retinal pigment epithelium-derived CTLA-
generate T reg cells. Therefore, immunohistochemistry with anti-FOXP3 (T reg cells 
marker) Ab has been performed to detect the Treg cells in placenta. At the stage 10 
dpc, T reg presented in decidua layer with small population compare to labyrith layer. 
